American Academy of Family Physicians

Printer-friendly version

Share this on AAFP Connection

Share this page

More States Allocate Funds for Anti-Tobacco Programs in 2008

By Barbara Bittner

Nearly a decade ago, a historic multistate tobacco settlement promised a financial windfall for most U.S. states, and many public health organizations hoped the states would use a majority of the money to fund tobacco prevention and cessation programs. Now a new report outlines how well states have met that challenge.

Stock photographic image of cigarettes
According to the latest annual report (137-page PDF; About PDFs) issued by the Campaign for Tobacco-Free Kids, or CTFK; the American Heart Association; the American Lung Association; and the American Cancer Society Cancer Action Network, many states have used a portion of their share of these funds to bankroll anti-tobacco programs, but in most states, that funding still fails to meet minimum levels recommended by the CDC. Combined, states are providing less than half of CDC-recommended funding levels for tobacco prevention.

Some States Move in Right Direction

According to the report, some states are making progress in using the settlement funds, as well as other revenues, to beef up anti-tobacco efforts. Compared with last year, states overall increased their fiscal year 2008 funding for tobacco prevention and cessation programs by 20 percent to a total of $717.2 million, the highest level in six years. Three states -- Maine, Delaware and Colorado -- currently fund tobacco prevention programs at CDC minimum levels. Maine has ranked first in funding these programs for six years.

Florida had the greatest increase in funding, from $1 million for fiscal year 2007 to $58 million this budget year. That increase was driven by a state constitutional amendment approved by voters in 2006 that requires Florida to spend 15 percent of its annual tobacco settlement revenue on tobacco prevention.

Also among states that have increased tobacco prevention funding for 2008 are Indiana, Iowa, Oklahoma, South Dakota, Tennessee and Wisconsin.

Others Make Only Poor Showing

Unfortunately, the report includes a lot of bad news. Aside from the three states funding the programs at the minimum level recommended by the CDC, only 17 other states fund tobacco prevention and cessation programs at even half the minimum level. Even worse, 30 states and the District of Columbia are spending less than half of the CDC's recommended amount for these activities. Connecticut currently appropriates no funding for tobacco prevention at all.

This year, states are spending less than 3 percent of the $24.9 billion of revenue they will collect from the tobacco settlement and tobacco taxes on tobacco cessation and prevention. Meanwhile, tobacco companies spend at least $13.4 billion each year to market tobacco products, which means that they spend almost $19 on tobacco marketing for every $1 states spend to prevent kids from smoking and to help smokers quit.

States Will Get Second Chance

Most states will have yet another chance to increase funding for their anti-tobacco programs beginning this spring. A provision of the 1998 settlement calls for the 46 states, the District of Columbia and the U.S. territories that are parties to the settlement to receive so-called bonus payments totaling almost $1 billion per year starting in April 2008 and continuing for at least 10 years. Allocating those additional funds to states' tobacco prevention and cessation programs could greatly boost these states' abilities to reach out to their residents.

FPs Can Play Critical Role

FP Saria Carter Saccocio, M.D., of Fort Lauderdale, Fla., a member of the AAFP Tobacco Cessation Advisory Committee and a former state coordinator for the Academy's Tar Wars tobacco-free education program, called the report's findings "something to be excited about, but depressing because we're so excited about such a small change." Even so, she said, she has "guarded optimism" that things are going in the right direction, partly because of legislation such as that passed in Florida, as well as smoke-free workplace bills passed in many states. Moreover, she noted, tobacco taxes have been raised in several states.

Patricia Sosa, vice president for constituency relations at CTFK, and Carter Saccocio both see the report as a wake-up call for the nation, and they said that family physicians can play critical roles in the fight against tobacco use, both by persuading lawmakers to increase anti-tobacco program funding and by staging interventions at the patient level.

Sosa lauded the AAFP as a key medical organization in helping to secure more funding for these programs. The Academy, which is a member of CTFK's "Partners for Effective Tobacco Policy" coalition, currently has the largest number of constituent chapters that are active in the campaign's efforts, compared with participation among other medical organizations, she said.

Of all of CTFK's goals for 2008, Sosa said, the organization's number one priority is to pass legislation granting the FDA the power to regulate tobacco products. By doing so, it would give the FDA and public health organizations access to the ingredients included in tobacco products and could lead to less-addictive products. This legislation already has been introduced in both houses of Congress. In the House of Representatives, it currently has 217 sponsors; in the Senate, it has 55 sponsors.

Carter Saccocio encouraged members to use AAFP's Speak Out to contact federal and state legislators regarding all tobacco-related legislation. She also urged AAFP members to get involved in Tar Wars and the AAFP's Ask and Act program. Both Tar Wars and Ask and Act offer downloadable educational materials on their Web sites; physicians can use these materials in their practices when talking with patients. Carter Saccocio encouraged all family physicians to "give tobacco awareness 30 seconds during each patient encounter."

Share this on AAFP Connection

Search AAFP News Now

 

Health of the Public

AAFP, USPSTF Recommend Against Routine PSA Screening

Inadequate, Disordered Sleep Increases Diabetes Risk

Text Messaging Could Hike Vaccination Rates

Fluoroquinolones Tied to Greater Retinal Detachment Risk

Sanofi Announces DTaP Vaccine Shortage

AHRQ Resources Provide Ready Access to Research Data

Community-onset C. difficile Infections on the Rise

New FamilyDoctor.org Content Helps With Caring for Elderly

U.S. Measles Cases in 2011 Highest in 15 Years

FDA Warns of More Finasteride Side Effects

'Take-Back' Initiative Focuses on Destroying Unwanted Drugs

Bariatric Surgery May Help Combat Type 2 Diabetes

Certain Skin Products Tied to Mercury Poisoning

FDA Clarifies Citalopram Usage, Dosing Warnings

Veterans With PTSD at Heightened Risk for Opioid Abuse

ACP Releases Guideline on Type 2 Diabetes Management

Office Champions Seeking Applicants for Second Wave

Surgeon General Releases Report on Teen Smoking

USPSTF Issues Final Cervical Cancer Screening Recommendations

FDA Approves First Quadrivalent Influenza Vaccine

Survey: Physicians May Have Trouble Interpreting Cancer Statistics

AIM-HI Nutrition Questionnaire Can Open Dialogue

Statin, HIV/Hepatitis C Drug Interactions May Pose Risks

Statin Therapy Effective in Both Genders, Study Suggests

AAFP, CDC Announce Immunization Schedule Change

Family Physicians on Front Lines of Caring for Vets

ACIP Votes to Expand Tdap Recommendation

Recalled Oral Contraceptives Pose Pregnancy Risk

Studies Shed Light on Vaccine Side Effect Risks

Dosing Problems Prompt Recall of Infants' Tylenol Products

TB 'Superbug' Not Stateside Threat, Says FP

Adult Vaccination Coverage Remains Low, Says CDC

FDA Warns of Health Risk Tied to PPI Use

Study: PPI Does Not Routinely Improve Asthma Control

Recalled Oral Contraceptives Pose Pregnancy Risk

CDC to Fund 2D Vaccine Barcoding Pilot

2012 Immunization Schedules Reflect Multiple Changes

Study: Cognitive Decline Detected in Middle-aged Adults

CDC Toolkit Can Help Clinicians Fight Norovirus Infection

Patient-Centered Care Linked to Lower Mortality

Study: Inappropriate Cancer Screenings Continue

Novartis Manufacturing Plant Closes After Drug Mix-ups

FDA Announces Classwide REMS for TIRF Medications